VitaDX is a startup applying artificial intelligence to the healthcare sector, and more specifically to the early diagnosis of cancer by exploiting fluorescence imaging in favor of a first product, VisioCyt®, dedicated to the detection of cancer of the bladder. This solution will allow the diagnosis of bladder cancer from a simple urine sample toimprove the performance of urinary cytology conventionally used in first intention.

Biotechnology

VitaDX

The Rennes office likely focuses on strategic oversight and governance, supporting regional initiatives and board activities.

People (1)

Jobs (0)

Other offices